REG - Spire Healthcare Grp - Notice of AGM

Spire HealthcareAnnouncement

04/04/2024 11:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240404:nRSD3450Ja&default-theme=true

RNS Number : 3450J  Spire Healthcare Group PLC  04 April 2024

 

Spire Healthcare Group plc

 

4 April 2024

 

2023 Annual Report and 2024 Notice of Annual General Meeting

 

Spire Healthcare Group plc (the "Company") released its preliminary
announcement of its annual results for the year ended 31 December 2023
("Preliminary Announcement") on Thursday, 29 February 2024.

 

Further to that Preliminary Announcement, the Company confirms that its Annual
Report and Accounts for the year ended 31 December 2023 ("2023 Annual
Report"), 2024 Notice of Annual General Meeting and Form of Proxy have now
been published. Printed copies have been posted to shareholders who have
requested hard copies.

 

The following documents are available on the Company's website:

 

2023 Annual Report:               www.spirehealthcare.com/AR2023

2024 Notice of Meeting:         www.spirehealthcare.com/Notice2024

 

In accordance with the Financial Conduct Authority's ("FCA") Listing Rule
9.6.1 R, the Company will submit its 2023 Annual Report and other shareholder
documents to the National Storage Mechanism. These documents should be
available for inspection within two working days at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

In accordance with the FCA's Disclosure and Transparency Rules ("DTRs") the
regulated information required to be communicated under DTR 6.3.5R(1A) is
available in unedited full text within the 2023 Annual Report which will be
available both on the National Storage Mechanism and on the Company's website
www.spirehealthcare.com.

 

Arrangements for the Annual General Meeting

The Annual General Meeting of the Company will be held at 11.00am on Thursday,
9 May 2024 at 3 Dorset Rise, London EC4Y 8EN (the "2024 AGM").

 

The Company welcomes shareholders to attend the 2024 AGM in person but are
asked to monitor the Company's website should any changes in requirements on
attending the meeting be necessary.

 

The Board always welcomes questions from shareholders and we request that
these are submitted by e-mail to companysecretary@spirehealthcare.com
(mailto:companysecretary@spirehealthcare.com) . Answers to questions received
will be placed on the Company's website ahead of the meeting.

 

Details of the resolutions to be proposed at the 2024 AGM are set out in the
2024 Notice of Meeting. The voting results of all resolutions put before the
2024 AGM will be announced to the market following the meeting.

 

 

Enquiries:

Philip Davies

Company Secretary

Tel: 07803 508348

 

About Spire Healthcare

Spire Healthcare (http://www.spirehealthcare.com) is a leading independent
healthcare group in the United Kingdom, running 39 hospitals and over 50
clinics, medical centres and consulting rooms across England, Wales and
Scotland. It operates a network of private GPs and provides occupational
health services to over 800 corporate clients.

Working in partnership with over 8,600 experienced consultants, Spire
Healthcare delivered tailored, personalised care to over one million
inpatients, outpatients and daycase patients, and occupational health
programme clients, in 2023, and is the leading private provider, by volume, of
knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. It also delivers a range of private and NHS
mental health, musculoskeletal and dermatological services.

Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good,'
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOASSFFSLELSEFL